No Data
These Are the Stocks With the Largest Changes in Short Interest in July - GS
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Arcadia Biosciences (RKDA)
H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $16
Summit Therapeutics Analyst Ratings
Express News | Summit Therapeutics PLC : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $16
Express News | Two Ivonescimab (Pd-1/Vegf) Results Including Phase 3 Monotherapy Versus Pembrolizumab Monotherapy in First-Line Treatment for Pd-L1 Positive Nsclc to Be Presented at Wclc 2024
KingNY-Life : I agree very much. This stock had the fewest at the end of the year30USD
Greg Hagy : ITS A DAY TRADE STOCK